Edition:
United Kingdom

People: Shin Nippon Biomedical Laboratories Ltd (2395.T)

2395.T on Tokyo Stock Exchange

754JPY
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
¥754
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
567,047
52-wk High
¥980
52-wk Low
¥442

Takanashi, Ken 

Mr. Ken Takanashi has been serving as Chief Operating Officer, Vice President and Representative Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. since June 29, 2017. He joined the Company in December 2002. His previous titles include Deputy Chief Director of Global Business Development, Vice President of Translational Research Company, President of TR Business Company, Vice President of NDS Business Company, Deputy Director of Business Planning, Manager of New Business Office and President of Translational Research Company. He previously worked for Mitsubishi Corporation and SUASA KRISTAL(M)BERHAD before joining the Company. He is a Chartered Public Accountant.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --